CK7 and consensus molecular subtypes as major prognosticators in (V600E)BRAF mutated metastatic colorectal cancer

BACKGROUND: (V600E)BRAF mutated metastatic colorectal cancer (mCRC) is a subtype (10%) with overall poor prognosis, but the clinical experience suggests a great heterogeneity in survival. It is still unexplored the real distribution of traditional and innovative biomarkers among (V600E)BRAF mutated...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Br J Cancer
Auteurs principaux: Loupakis, Fotios, Biason, Paola, Prete, Alessandra Anna, Cremolini, Chiara, Pietrantonio, Filippo, Pella, Nicoletta, Dell’Aquila, Emanuela, Sperti, Elisa, Zichi, Clizia, Intini, Rossana, Dadduzio, Vincenzo, Schirripa, Marta, Bergamo, Francesca, Antoniotti, Carlotta, Morano, Federica, Cortiula, Francesco, De Maglio, Giovanna, Rimassa, Lorenza, Smiroldo, Valeria, Calvetti, Lorenzo, Aprile, Giuseppe, Salvatore, Lisa, Santini, Daniele, Munari, Giada, Salmaso, Roberta, Guzzardo, Vincenza, Mescoli, Claudia, Lonardi, Sara, Rugge, Massimo, Zagonel, Vittorina, Di Maio, Massimo, Fassan, Matteo
Format: Artigo
Langue:Inglês
Publié: Nature Publishing Group UK 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6889398/
https://ncbi.nlm.nih.gov/pubmed/31474758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-019-0560-0
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires